vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and SMARTFINANCIAL INC. (SMBK). Click either name above to swap in a different company.
SMARTFINANCIAL INC. is the larger business by last-quarter revenue ($53.8M vs $44.9M, roughly 1.2× AbCellera Biologics Inc.). SMARTFINANCIAL INC. runs the higher net margin — 25.4% vs -19.9%, a 45.4% gap on every dollar of revenue. Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 15.4%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
SmartFinancial Inc. is a U.S.-based bank holding company that operates its wholly owned subsidiary SmartBank. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, mortgage services, and wealth management solutions, primarily serving individual customers and small-to-medium enterprises across the Southeastern United States.
ABCL vs SMBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $53.8M |
| Net Profit | $-8.9M | $13.7M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | — |
| Net Margin | -19.9% | 25.4% |
| Revenue YoY | 788.4% | — |
| Net Profit YoY | 73.9% | 21.6% |
| EPS (diluted) | $-0.03 | $0.81 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $53.8M | ||
| Q4 25 | $44.9M | $53.3M | ||
| Q3 25 | $9.0M | $51.1M | ||
| Q2 25 | $17.1M | $49.2M | ||
| Q1 25 | $4.2M | $46.8M | ||
| Q4 24 | $5.0M | $46.8M | ||
| Q3 24 | $6.5M | $44.2M | ||
| Q2 24 | $7.3M | $40.4M |
| Q1 26 | — | $13.7M | ||
| Q4 25 | $-8.9M | $13.7M | ||
| Q3 25 | $-57.1M | $13.7M | ||
| Q2 25 | $-34.7M | $11.7M | ||
| Q1 25 | $-45.6M | $11.3M | ||
| Q4 24 | — | $9.6M | ||
| Q3 24 | $-51.1M | $9.1M | ||
| Q2 24 | $-36.9M | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | -63.7% | 31.3% | ||
| Q3 25 | -851.8% | 33.2% | ||
| Q2 25 | -290.2% | 29.0% | ||
| Q1 25 | -1479.6% | 29.0% | ||
| Q4 24 | — | 26.5% | ||
| Q3 24 | -1439.4% | 24.3% | ||
| Q2 24 | -1276.2% | 25.6% |
| Q1 26 | — | 25.4% | ||
| Q4 25 | -19.9% | 25.7% | ||
| Q3 25 | -637.8% | 26.8% | ||
| Q2 25 | -203.3% | 23.8% | ||
| Q1 25 | -1077.2% | 24.0% | ||
| Q4 24 | — | 20.6% | ||
| Q3 24 | -785.4% | 20.7% | ||
| Q2 24 | -504.3% | 19.8% |
| Q1 26 | — | $0.81 | ||
| Q4 25 | $-0.03 | $0.81 | ||
| Q3 25 | $-0.19 | $0.81 | ||
| Q2 25 | $-0.12 | $0.69 | ||
| Q1 25 | $-0.15 | $0.67 | ||
| Q4 24 | — | $0.57 | ||
| Q3 24 | $-0.17 | $0.54 | ||
| Q2 24 | $-0.13 | $0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $346.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $562.2M |
| Total Assets | $1.4B | $5.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $346.1M | ||
| Q4 25 | $128.5M | $464.4M | ||
| Q3 25 | $83.2M | $557.1M | ||
| Q2 25 | $92.4M | $365.1M | ||
| Q1 25 | $159.3M | $423.0M | ||
| Q4 24 | $156.3M | $387.6M | ||
| Q3 24 | $126.6M | $192.9M | ||
| Q2 24 | $148.3M | $342.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $1.3M | ||
| Q2 25 | — | $7.0M | ||
| Q1 25 | — | $7.6M | ||
| Q4 24 | — | $8.1M | ||
| Q3 24 | — | $9.0M | ||
| Q2 24 | — | $12.7M |
| Q1 26 | — | $562.2M | ||
| Q4 25 | $966.9M | $552.4M | ||
| Q3 25 | $964.0M | $538.4M | ||
| Q2 25 | $1.0B | $519.0M | ||
| Q1 25 | $1.0B | $505.8M | ||
| Q4 24 | $1.1B | $491.3M | ||
| Q3 24 | $1.1B | $489.0M | ||
| Q2 24 | $1.1B | $472.5M |
| Q1 26 | — | $5.9B | ||
| Q4 25 | $1.4B | $5.9B | ||
| Q3 25 | $1.4B | $5.8B | ||
| Q2 25 | $1.4B | $5.5B | ||
| Q1 25 | $1.3B | $5.4B | ||
| Q4 24 | $1.4B | $5.3B | ||
| Q3 24 | $1.4B | $4.9B | ||
| Q2 24 | $1.4B | $4.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | — |
| Free Cash FlowOCF − Capex | $-44.6M | — |
| FCF MarginFCF / Revenue | -99.4% | — |
| Capex IntensityCapex / Revenue | 21.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-34.7M | $61.7M | ||
| Q3 25 | $-52.6M | $16.9M | ||
| Q2 25 | $-32.4M | $14.0M | ||
| Q1 25 | $-11.6M | $14.3M | ||
| Q4 24 | $-108.6M | $52.7M | ||
| Q3 24 | $-28.9M | $12.4M | ||
| Q2 24 | $-30.0M | $16.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-44.6M | $59.3M | ||
| Q3 25 | $-61.5M | $16.6M | ||
| Q2 25 | $-45.8M | $13.2M | ||
| Q1 25 | $-22.2M | $13.4M | ||
| Q4 24 | $-187.0M | $46.3M | ||
| Q3 24 | $-47.4M | $11.3M | ||
| Q2 24 | $-50.1M | $15.4M |
| Q1 26 | — | — | ||
| Q4 25 | -99.4% | 111.3% | ||
| Q3 25 | -687.0% | 32.4% | ||
| Q2 25 | -267.9% | 26.9% | ||
| Q1 25 | -524.0% | 28.5% | ||
| Q4 24 | -3702.8% | 98.9% | ||
| Q3 24 | -728.4% | 25.7% | ||
| Q2 24 | -683.8% | 38.2% |
| Q1 26 | — | — | ||
| Q4 25 | 21.9% | 4.5% | ||
| Q3 25 | 99.7% | 0.6% | ||
| Q2 25 | 78.2% | 1.6% | ||
| Q1 25 | 251.1% | 2.0% | ||
| Q4 24 | 1552.7% | 13.7% | ||
| Q3 24 | 284.6% | 2.4% | ||
| Q2 24 | 274.6% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.50× | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 1.20× | ||
| Q1 25 | — | 1.27× | ||
| Q4 24 | — | 5.47× | ||
| Q3 24 | — | 1.36× | ||
| Q2 24 | — | 2.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
SMBK
| Net Interest Income | $45.9M | 85% |
| Noninterest Income | $7.9M | 15% |
